Tradestie Institutional Equity Comparison Engine
MBIO vs DARE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MBIO Overall Edge
MBIO Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mustang Bio, Inc. (MBIO) driven by superior Growth & Margin, Momentum & Technical while DARE counters with relative strength in Valuation. Fundamentally, MBIO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DARE at 1.3x Forward P/E and -813.4% operating margin (+499.6% YoY). In options structure, MBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DARE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DARE
MBIO N/M vs DARE 1.3x Fwd P/E
Growth & Margin Winner
MBIO
Op Margin 0.0% vs -813.4% ยท YoY +0.0% vs +499.6%
Momentum & Technical Winner
MBIO
1Y -67.4% vs -69.1% ยท 52W Pos 4% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MBIO
NASDAQ
Mustang Bio, Inc.
Pharmaceutical Preparations
$0.39
-6.34% 1D
Market Cap
$3.2M
1M Return
+4.86%
1Y Return
-67.38%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 40.0
Fund 49.0
Flow 50.0
Mom 70.0
DARE
NASDAQ
Dare Bioscience, Inc. Common Stock
Pharmaceutical Preparations
$0.58
-11.13% 1D
Market Cap
$12.9M
1M Return
-19.38%
1Y Return
-69.09%
Forward P/E
1.3x
Unified AI Score
45.7 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MBIO -67.38%
DARE -69.09%
Spread: +1.71 pp (MBIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MBIO TTM Op. Margin: 0.0%
DARE TTM Op. Margin: -813.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBIO vs DARE. Trailing 12-month operating profitability (MBIO 0.0% vs DARE -813.4%) and valuation multiples (MBIO N/M vs DARE 1.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MBIO | DARE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.2M | $12.9M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Forward P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Revenue Growth (YoY) Growth | +0.0% | +499.6% | Higher Growth | DARE |
| Operating Margin (TTM) Profitability | 0.0% | -813.4% | Higher Margin | MBIO |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -43.1% | -2543.1% | Higher ROE | MBIO |
| 52-Week Range Position Momentum | 4% ($0โ$1) | 0% ($1โ$4) | Stronger Trend | MBIO |
| Beta / 30D Volatility Risk Regime | 0.66ฮฒ ยท 86% Vol | 1.40ฮฒ ยท 62% Vol | Lower Realized Risk | DARE |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 45.7 / 100 (HOLD) | Higher Composite | DARE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MBIO vs DARE Buy Guide
MBIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DARE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MBIO nor DARE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.